Hyperlipidemias and Atherosclerotic Cardiovascular Disease

5/5 ( ratings)

The purpose of this course is to increase awareness of the crucial role of hyperlipidemias in the development of cardiovascular disease, evaluate the therapeutic benefits of pharmacologic and nonpharmacologic approaches to lipid control, and contribute to a more positive interaction between the healthcare professional and the patient, through fostering patient awareness, implementation of lifestyle changes, and compliance to therapy. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.

Upon completion of this course, you should be able to:

1. Discuss the incidence of cardiovascular disorders, expected epidemiologic trends, and relevance to society and healthcare systems.
2. Discuss the relevance of hyperlipidemias in the etiology of atherosclerosis and cardiovascular diseases.
3. Identify risk factors for hyperlipidemias.
4. Describe the exogenous and endogenous pathways of lipid synthesis and metabolism.
5. Describe the various types of lipoproteins.
6. Evaluate lipid profiles and identify the most clinically relevant types of hyperlipidemias.
7. Analyze the importance of lifestyle modification in managing hyperlipidemias.
8. Discuss the targeting of specific steps in lipid synthesis and metabolism related to the mechanism of action of drugs that inhibit cholesterol absorption in the intestine.
9. Describe the therapeutic efficacy and indications of fibrates, statins, and nicotinic acid derivatives.
10. Determine the role of fish oil derivatives and sterols and stanols in the management of hyperlipidemias.
11. Identify patients at risk for coronary heart disease and outline the evidence-based guidelines for the treatment of these patients.

This 10-hour continuing education course is available for download for professional development; if continuing education credit is desired, please see instructions included in eBook.